Published Date: 23-Sep-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Radiation Oncology Market size is expected to reach $12.8 billion by 2028, rising at a market growth of 8.5% CAGR during the forecast period.
The Colorectal Cancer segment is showcasing CAGR of 9.2% during (2022 - 2028). The colon or the rectum is where colorectal cancer begins. Depending on where they first appear, these malignancies may also be referred to as colon or rectal cancer. Rectal cancer and colon cancer are frequently combined because they share many characteristics. When body cells begin to proliferate out of control, cancer develops to discover more about the origins and progression of cancer.
The External Beam Radiation Therapy segment acquired maximum revenue share in the Global Radiation Oncology Market by Type in 2021 thereby, achieving a market value of $9.5 billion by 2028. Due to the accuracy of the direct beams at the diseased cells, which causes less damage to normal tissues, allowing physicians to use larger doses of radiotherapy for therapy and increase the cancer population, this trend is anticipated to continue during the projected period.
The North America market dominated the Global Radiation Oncology Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $4.5 billion by 2028.The Europe market is exhibiting a CAGR of 7.8% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 9.4% during (2022 - 2028).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Becton, Dickinson and Company, Varian Medical Systems, Inc., Ion Beam Applications SA, Elekta AB, Accuray Incorporated, Nordion Inc. (Sotera Health LLC), Isoray Inc., Mevion Medical Systems, Inc., Provision Healthcare, and Panacea Medical Technologies Pvt. Ltd.
Unique Offerings from KBV Research